Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea · Delayed Price · Currency is KRW 7,070.00
-120.00 (-1.67%)
Dec 10, 2025, 3:30 PM KST
Komipharm International Market Cap
Komipharm International has a market cap or net worth of 519.22 billion as of December 10, 2025. Its market cap has increased by 85.06% in one year.
Market Cap
519.22B
Enterprise Value
534.68B
Revenue
56.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,070.00
Market Cap Chart
Since March 1, 2002, Komipharm International's market cap has increased from 94.26B to 519.22B, an increase of 450.83%. That is a compound annual growth rate of 7.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 519.22B | 94.16% |
| Dec 30, 2024 | 267.41B | -9.03% |
| Dec 28, 2023 | 293.94B | -34.10% |
| Dec 29, 2022 | 446.06B | -18.67% |
| Dec 30, 2021 | 548.45B | -36.13% |
| Dec 30, 2020 | 858.75B | -11.44% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.84T |
| Celltrion | 40.98T |
| ALTEOGEN | 24.44T |
| SK Biopharmaceuticals | 10.58T |
| ABL Bio | 10.26T |
| Yuhan | 8.70T |
| LigaChem Biosciences | 6.67T |
| HLB Co., Ltd. | 6.49T |